Simple jQuery Dropdowns

Statistics

Total Visits

Views
Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: A randomized controlled trial 45

Total Visits per Month

December 2019 January 2020 February 2020 March 2020 April 2020 May 2020 June 2020
Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: A randomized controlled trial 0 2 0 8 3 7 0

File Downloads

Views

Top Country Views

Views

Top City Views

Views